SARS-CoV-2, Influenza A, Influenza B, Adenovirus, Respiratory Syncytial Virus A/B, Human Metapneumovirus, Rhinovirus, Parainfluenza 3, Parainfluenza 4, Parainfluenza 2, Parainfluenza 1, Serratia Marcescens, Moraxella catarrhalis, Pseudomonas Aeruginosa, Mycoplasma pneumoniae, Haemophilus Influenzae A/B, Staphylococcus aureus, Streptococcus agalactiae, Legionella pneumophila, Chlamydia pneumoniae, Streptococcus pneumoniae, Klebsiella aerogenes, Klebsiella pneumoniae, Streptococcus pyogenes, Enterovirus spp., Enterovirus D68.
Detection and identification of viral and bacterial nucleic acids in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection. Aids in rapid diagnosis of co-infections and guides appropriate antimicrobial therapy by distinguishing among multiple pathogenic causes of respiratory illness.
Only detects nucleic acids specifically included in the panel. Can detect DNA and RNA from dead/non-viable organisms. Results should be considered in the context of the presence of clinical signs and symptoms.
| Condition | Duration |
|---|---|
| Refrigerated (2–8°C) | Up to 72 hours |